About this trail:
GlaxoSmithKline, the makers of Dexedrine, recently told doctors about the drug's new labelling. The company warned that there have been cases of sudden death, myocardial infarction and strokes among adult patients talking Dexedrine at normal doses. There are also risks for patients with existing psychotic disorders when they take these drugs, such as delusional thinking, hallucinations and aggression.
Trail link: http://trailfire.com/brettbum/trails/10772
Summary: http://trailfire.com/brettbum/trailview/10772
Summary: http://trailfire.com/brettbum/trailview/10772
0
0
Tags
Similar Trails
1
GlaxoSmithKline, the makers of Dexedrine, recently told doctors about the drug's new labelling. The company warned that there have been cases of sudden death, myocardial infarction and strokes among adult patients talking Dexedrine at normal doses. There are also risks for patients with existing psychotic disorders when they take these drugs, such as delusional thinking, hallucinations and aggression.
